amfAR, The Foundation for AIDS Research
TREAT Asia (Therapeutics Research, Education,
and AIDS Training in Asia) is a network of clinics, hospitals, and research
institutions working with civil society to ensure the safe and effective
delivery of HIV/AIDS treatments throughout Asia and the Pacific.
What should be the highest priority in 2018 for ending AIDS in the Asia-Pacific region?
The TREAT Asia Report Interview: Dr. Praphan Phanuphak
Stigma and HIV reinforce one another and fan the flames of the HIV/AIDS epidemic.
The TREAT Asia Report Interview: Eamonn Murphy, UNAIDS Director, Regional Support Team for Asia and the Pacific
The TREAT Asia Report Interview: Dr. François Dabis, Director of the French National Agency for Research on AIDS and Viral Hepatitis (ANRS)
Get regular email updates and analysis about the most pressing AIDS-related issues facing the Asia-Pacific region.
Dolutegravir (DTG) is a well-tolerated antiretroviral drug that is increasingly recognized as a potential first-line option for the treatment of HIV. This clinical brief is available in English, Bahasa Indonesia, Chinese Mandarin, Japanese, Khmer, Korean, Malay, Thai and Vietnamese.
In collaboration with young people living with HIV, social workers, and pediatricians in the Asia-Pacific region, TREAT Asia has developed tools to help providers manage the transition of adolescents from pediatric to adult HIV clinics.
The Thai Network of People Living with HIV/AIDS and AIDS Access Foundation urge employers to focus on job candidates’ abilities and qualifications, not their HIV status.
© 2018 amfAR All Rights Reserved